Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy

Europace

Volumn 14, Issue 11, 2012, Pages 1596-1601

  Kreuz, Jens ^a   Horlbeck, Fritz ^a   Linhart, Markus ^a   Mellert, Fritz ^a   Fimmers, Rolf ^a   Schrickel, Jan ^a   Nickenig, Georg ^a   Schwab, Jörg Otto ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Cardiac resynchronization therapy; Overall mortality; Renal dysfunction; Risk stratification

Indexed keywords

AMIODARONE; PHENPROCOUMON;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIODARONE; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; GERMANY; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84868547349     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus152     Document Type: Article

References (35)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
4. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al., American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
5. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346: 1845-53. (Pubitemid 34603028)
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-50.
7. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
8. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al., MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-38.
9. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S et al. Cardiac resynchronization therapy for mild-to-moderate heart failure. Resynchronization- Defibrillation for Ambulatory Heart Failure Trial Investigators. N Engl J Med 2010; 363:2385-95.
10. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36.
11. Huang Y, Wu W, Cao Y, Qu N. All cause mortality of cardiac resynchronization therapy with implantable cardioverter defibrillator: a meta-analysis of randomized controlled trials. Int J Cardiol 2010;145:413-7.
12. Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K et al. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol 2008;19:1259-65.
13. Lin G, Gersh BJ, Greene EL, Redfield MM, Hayes DL, Brady PA. Renal function and mortality following cardiac resynchronization therapy. Eur Heart J 2011;32: 184-90.
14. Fumagalli S, Valsecchi S, Boriani G, Gasparini M, Landolina M, Lunati M et al. Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (,65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry). Am J Cardiol 2011;107:1510-6.
15. Voigt A, Shalaby A, Adelstein E, Saba S. Beta-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy. Clin Cardiol 2010;33:E1-5.
16. Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P et al. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. J Card Fail 2007;13:769-73. (Pubitemid 350064500)
17. Sumner AD, Boehmer JP, Saxon LA, Carson P, Feldman AM, Galle E et al. Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy. Congest Heart Fail 2009;15:159-64.
18. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D et al. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Card Fail 2008;14:670-5.
19. Saxon LA, Bristow MR, Boehmer J, Krueger S, Kass DA, De Marco T et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 2006;114:2766-72. (Pubitemid 46018278)
20. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology. Eur Heart J 2008;29:2388-442.
21. Mullens W, Kepa J, De Vusser P, Vercammen J, Rivero-Ayerza M, Wagner P et al. Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. Am J Cardiol 2011;108:409-15.
22. Piccini JP, Berger JS, O'Connor CM. Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. Eur Heart J 2009; 30:1245-53. Review.
23. Chan AL, Hsieh HJ, Hsieh YA, Lin SJ. Fatal amiodarone-induced hepatotoxicity: a case report and literature review. Int J Clin Pharmacol Ther 2008;46:96-101. Review. (Pubitemid 351233795)
24. Conen D, Melly L, Kaufmann C, Bilz S, Ammann P, Schaer B et al. Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome. J Am Coll Cardiol 2007;49:2350-5. (Pubitemid 46891714)
25. Coudert B, Bailly F, Lombard JN, Andre F, Camus P. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature. Chest 1992;102:1005-12. Review.
26. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES et al., Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165-71. (Pubitemid 43076435)
27. Ho AT, Pai SM, Timothy P, Pai RG. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2005;28:647-53. (Pubitemid 40995465)
28. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82.
29. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
30. Dichtl W, Wolber T, Paoli U, Brullmann S, Stuhlinger M, Berger T et al. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 2011;34:433-6.
31. Larsen GK, Evans J, Lambert WE, Chen Y, Raitt M. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2011;8: 1881-6.
32. Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010;7:353-60.
33. Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;57:2416-23.
34. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M et al. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. CardioFit Multicenter Trial Investigators. Eur Heart J 2011; 32:847-55.
35. Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J 2011;161: 329-337, e1-2